Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in nephrology.

Aleix Cases1

  • 1Dialysis Section, Nephrology Department, Hospital Clinic i Provincial, University of Barcelona, Barcelona, Spain. acases@medicina.ub.es

Drug News & Perspectives
|December 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty and Congestion in Patients with Heart Failure: Clinical Interaction and Prognostic Implications.

Journal of clinical medicine·2026
Same author

Common Biomarkers of Endothelial Dysfunction Across Highly Prevalent Diseases with Cardiovascular Risk: Functional Characterization and Prognostic Implications.

International journal of molecular sciences·2026
Same author

Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity.

Renal failure·2026
Same author

Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study.

Nefrologia·2026
Same author

Interaction Between Frailty and Renal Function in Patients with Heart Failure.

Life (Basel, Switzerland)·2026
Same author

KDIGO 2026 clinical practice guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP).

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

New drug discovery and development in India.

Drug news & perspectives·2013
Same journal

Are we living in the end of the blockbuster drug era?

Drug news & perspectives·2010
Same journal

Molecule of the Month. TAK-875.

Drug news & perspectives·2010
Same journal

Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.

Drug news & perspectives·2010
Same journal

Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?

Drug news & perspectives·2010
Same journal

Trioxaquines: hybrid molecules for the treatment of malaria.

Drug news & perspectives·2010
See all related articles

The World Congress of Nephrology highlighted advances in treating Fabry's disease, anemia in chronic kidney disease, and secondary hyperparathyroidism. New therapies for renal transplant recipients were also presented, showcasing progress in nephrology.

Area of Science:

  • Nephrology
  • Clinical Science
  • Biochemistry

Background:

  • The World Congress of Nephrology convened in Berlin in 2003, gathering approximately 9,000 global scientists and clinicians.
  • The congress focused on cutting-edge advancements in both fundamental and applied nephrology research.

Framework:

  • Discussions included enzyme replacement therapy for Fabry's disease.
  • Novel erythropoietic agents, such as darbepoetin alfa (continuous erythropoiesis receptor activator), were evaluated for treating anemia in chronic kidney disease patients.
  • Management strategies for secondary hyperparathyroidism and calcium-phosphorus imbalances in uremia were explored, featuring calcimimetic agents and innovative phosphate binders like lanthanum carbonate.

Implementation:

  • The efficacy and safety of new immunosuppressive agents and their combinations for renal transplant recipients were presented.

Related Experiment Videos

  • Clinical trial results and therapeutic outcomes were central to the presentations.

    • Implications:

    • The congress underscored significant progress in managing complex kidney diseases and post-transplant care.
    • These advancements promise improved patient outcomes and novel therapeutic approaches in nephrology.